All In Biotech

Free tool

FAERS Monitor: Sensorcaine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018304 or its brand name (Sensorcaine, Bupivacaine Hydrochloride, Epinephrine Bitartrate). Reports on generic versions are filed under their own applications.

Reports

2,545

Serious

1,664

65% of reports

Hospitalization

649

Death reported

231

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective653
  • anaesthetic complication215
  • musculoskeletal pain202
  • maternal exposure during pregnancy196
  • off label use180
  • hypoaesthesia152
  • hypotension128
  • condition aggravated126
  • joint injury126
  • dyspnoea122
  • hypertension118
  • headache114
  • fatigue99
  • dizziness98
  • joint range of motion decreased98

Reports by year received

View as table
YearReports
200420
200510
200630
200714
200828
2009158
201078
201139
201237
201337
201428
2015106
2016283
201735
201878
201988
2020107
2021138
2022255
2023188
2024275
2025302
2026211

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,614 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaesthetic complicationSignal215719.1629.1141,210
joint range of motion decreasedSignal9860.850.05,667
joint injurySignal12649.041.35,852
musculoskeletal painSignal20232.028.06,024
maternal exposure during pregnancySignal19618.215.93,178
hypoaesthesiaSignal1528.47.2990
hypotensionSignal1285.34.5443
hypertensionSignal1184.63.9333
drug ineffectiveSignal6534.13.81,626
condition aggravatedSignal1263.42.9217
dyspnoea1221.81.542
off label use1801.71.553
dizziness981.61.323
headache1141.51.319
fatigue991.10.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.